Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Manufacturingchemist

Published November 12, 2026 · Updated November 13, 2026

The future of psychedelic drug design in mental health treatment - Manufacturing Chemist

Read the full story at Manufacturingchemist

Substances such as ketamine , psilocybin, lysergic acid ... Psychedelic- assisted therapy is different because it can involve a much.

Surfaced by 2 Google Alerts

  • Ketamine therapy
  • Psychedelic biotech